Literature DB >> 15705148

Corticosteroid-responsive interstitial pneumonitis related to imantinib mesylate with successful rechallenge, and potential causative mechanisms.

P Grimison, D Goldstein, J Schneeweiss, N Murray.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15705148     DOI： 10.1111/j.1445-5994.2004.00757.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN： 1444-0903            Impact factor:   2.048


× No keyword cloud information.
  5 in total

Review 1.  Tyrosine Kinase Inhibitor-Induced Interstitial Lung Disease: Clinical Features, Diagnostic Challenges, and Therapeutic Dilemmas.

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2016-11       Impact factor: 5.606

Review 2.  Infiltrative lung diseases: complications of novel antineoplastic agents in patients with hematological malignancies.

Authors:  Bobbak Vahid; Paul E Marik
Journal:  Can Respir J       Date:  2008 May-Jun       Impact factor: 2.409

3.  Imatinib-induced dose-dependent interstitial lung disease successfully switched to nilotinib: a case report with concentration exposure data.

Authors:  Kim Dao; Dana Védy; José Lopez; Olivier Staneczek; Thierry Buclin; Françoise Livio
Journal:  Int J Hematol       Date:  2012-12-28       Impact factor: 2.490

4.  Imatinib-induced irreversible interstitial lung disease: A case report.

Authors:  Ping Zhang; Jingfeng Huang; Fangfang Jin; Jiaohai Pan; Guifang Ouyang
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.889

5.  Nilotinib-induced interstitial lung disease.

Authors:  Se-Il Go; Won Sup Lee; Gyeong-Won Lee; Jung Hun Kang; Myung Hee Kang; Jeong-Hee Lee; Hoon-Gu Kim
Journal:  Int J Hematol       Date:  2013-07-23       Impact factor: 2.490
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.